Psychedelics in the News
Psychedelic plants and therapies have been receiving a lot of press lately. From Psilocybin for the treatment of PTSD, End of Life Trauma and nicotine/alchohol addiction, Iboga for the opiate addiction to Cannabis for a wide variety of physical and psychological ailmets (Yes, Cannabis is a Schedule 1 psychedelic) psychedelics are showing great promise in helping individuals improve the quality of their lives. Follow the links below for full stories on current psychedelic research.
PLEDG does not encourage, condone or endorse consumption of illegal substances.
PLEDG INC. is a 501(c)(3) non-profit organization dedicated to advocacy through research of psychedelic plant therapies. Our goals are in our name.
By partnering with researchers and retreat centers we are sponsoring legal psychedelic therapy and collecting data on the benefits of ethnobotanicals, primarily psilocybin to increase awareness and access to these highly beneficial therapies.
Our unique partnership with MycoMeditations allows PLEDG to offer scholarship program for those in need to access psychedelic therapies.
PLEDG is an education and advocacy organization focusing on psilocybin therapy. Through partnerships with retreat facilities we provide scholarships for psilocybin therapies to disadvantaged communities.
Are you a physician, psychiatrist or researcher who has interest in working with psilocybin?
Are you a citizen interested in therapeutic applications of psychedelics?
Call or email to find out how you can get involved.
Donations directly assist
individuals suffering from cancer anxiety, PTSD, addiction and treatment resistant depression.
Our psilocybin scholarship program allows those with needs but limited resources to benefit from these life changing therapies.